文章詳目資料

輔仁醫學期刊

  • 加入收藏
  • 下載文章
篇名 The Role of Herbal Medication in Poor TACE Response Hepatocellular Carcinoma: Case Report
卷期 15:4
並列篇名 中藥在肝動脈栓塞治療效果不佳患者治療上的角色:病例報告
作者 方昭華蔡金川陳建霖陳建華詹正義
頁次 215-220
關鍵字 Chinese medicine-based treatmentHepatocellular carcinoma Transarterial chemoembolization 中藥治療肝癌經動脈栓塞
出刊日期 201712
DOI 10.3966/181020932017121504006

中文摘要

肝癌治療的原則,若適合開刀的患者仍是以開刀治療為主,若不適合開刀或不願意開刀的患者,則評估是否適合施行射頻燒灼術。若以上兩種痊癒性治療皆不適合,則考慮經動脈腫瘤栓塞治療。我們報告一個接受一次經動脈腫瘤栓塞治療的患者,一個月後追蹤電腦斷層發現效果不佳。病患想完全放棄治療,但與患者討論後建議先以中藥治療三個月,追蹤電腦斷層發現腫瘤明顯縮小,且再施行動脈腫瘤栓塞治療的效果奇佳。因此合併中藥治療對於一些經動脈腫瘤栓塞治療效果不佳的患者可能是可考慮的方法之一。

英文摘要

On principle, the treatment for hepatocellular carcinoma (HCC) generally involves surgeries. However, if patients are unfit or unwilling to undergo surgeries, medical personnel assess whether radiofrequency ablation is a viable option. If both of the aforementioned curative therapies are unsuitable, transarterial chemoembolization (TACE) may be considered. We report a patient who had undergone TACE and whose computed tomography (CT) scan during the 1-month follow-up showed unfavorable results, resulting in the patient deciding to withdraw from the treatment. After a discussion with the patient, 3 months of traditional Chinese medicine-based treatment were recommended. A follow-up CT scan indicated that the size of the tumor was reduced considerably, and that the application of TACE following the traditional Chinese medicine-based treatment yielded remarkable results. Thus, a combination of the two methods may be an option for patients whose liver cancer condition fails to improve after TACE.

相關文獻